Aprea Therapeutics, Inc.
APRE
$1.14
$0.1110.68%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
12/3/2025
-
Simply Wall St
11/15/2025
-
GuruFocus
11/12/2025
-
Ticker Report
11/12/2025
-
GuruFocus
11/12/2025
-
The Fly
11/12/2025
-
The Fly
11/12/2025
-
Globe Newswire
10/30/2025
-
Ticker Report
10/27/2025
-
TipRanks Financial Blog
10/27/2025
-
TipRanks Financial Blog
10/24/2025
-
GuruFocus
10/24/2025
-
GuruFocus
10/24/2025
-
TipRanks Financial Blog
10/24/2025
-
The Fly
10/24/2025
-
Globe Newswire
10/15/2025
-
GuruFocus
10/15/2025
-
GuruFocus
10/15/2025
-
The Fly
10/15/2025
-
Globe Newswire
10/14/2025
-
GuruFocus
10/14/2025
-
Globe Newswire
9/8/2025
-
TipRanks Financial Blog
8/28/2025
-
GuruFocus
8/28/2025
-
GuruFocus
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, November 12, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 23 and 27 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
215 948 4119
Address
3805 Old Easton Road
Doylestown, PA 18902
Doylestown, PA 18902
Country
Year Founded
--
Business Description
Sector
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage...
more